Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Tumor Biomarkers. Found 36 abstracts

no pagination
Pei J, Zhao X, Patchefsky AS, Flieder DB, Talarchek JN, Testa JR, Wei S. Clinical application of RNA sequencing in sarcoma diagnosis: An institutional experience. Medicine. 2019 Jun;98(25):e16031.   PMCID: PMC6636967
Choueiri TK, Plimack E, Arkenau HT, Jonasch E, Heng DY, Powles T, Frigault MM, Clark EA, Handzel AA, Gardner H, Morgan S, Albiges L, Pal SK. Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer. J Clin Oncol. 2017 Sep 10;35(26):2993-3001.
Fortner RT, Schock H, Jung S, Allen NE, Arslan AA, Brinton LA, Egleston BL, Falk RT, Gunter MJ, Helzlsouer KJ, Idahl A, Johnson TS, Kaaks R, Krogh V, Lundin E, Merritt MA, Navarro C, Onland-Moret NC, Palli D, Shu XO, Sluss PM, Staats PN, Trichopoulou A, Weiderpass E, Zeleniuch-Jacquotte A, Zheng W, Dorgan JF. Anti-Mullerian hormone and endometrial cancer: a multi-cohort study. Br J Cancer. 2017 Oct 24;117(9):1412-8.   PMCID: PMC5672934
Leclerc D, Pham DN, Levesque N, Truongcao M, Foulkes WD, Sapienza C, Rozen R. Oncogenic role of PDK4 in human colon cancer cells. Br J Cancer. 2017 Mar 28;116(7):930-6.   PMCID: PMC5379150
Lee HO, Uzzo RG, Kister D, Kruger WD. Combination of serum histidine and plasma tryptophan as a potential biomarker to detect clear cell renal cell carcinoma. Journal of translational medicine. 2017 Apr 06;15(1):72.   PMCID: PMC5383954
Moy RH, Huffman AP, Richman LP, Crisalli L, Wang XK, Hoxie JA, Mick R, Emerson SG, Zhang Y, Vonderheide RH, Porter DL, Reshef R. Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis. Blood. 2017 Feb 16;129(7):906-16.   PMCID: PMC5314813
Pollack A, Kwon D, Walker G, Khor LY, Horwitz EM, Buyyounouski MK, Stoyanova R. Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer. Journal of the National Cancer Institute. 2017 Feb;109(2):1-8.   PMCID: PMC6075027
Weidhaas JB, Harris J, Schaue D, Chen AM, Chin R, Axelrod R, El-Naggar AK, Singh AK, Galloway TJ, Raben D, Wang D, Matthiesen C, Avizonis VN, Manon RR, Yumen O, Nguyen-Tan PF, Trotti A, Skinner H, Zhang Q, Ferris RL, Sidransky D, Chung CH. The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2017 Apr;3(4):483-91.   PMCID: PMC5470422
Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016 May;122(9):1349-69.
McMahon B, Block J, Block T, Cohen C, Evans AA, Hosangadi A, London WT, Sherman M, Princeton HC. Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care. Journal of the National Cancer Institute. 2016 Apr;108(4).   PMCID: PMC4857154
Overman MJ, Morris V, Moinova H, Manyam G, Ensor J, Lee MS, Eng C, Kee B, Fogelman D, Shroff RT, LaFramboise T, Mazard T, Feng T, Hamilton S, Broom B, Lutterbaugh J, Issa JP, Markowitz SD, Kopetz S. Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin. Oncotarget. 2016 Oct 11;7(41):67495-506.   PMCID: PMC5341892
Wang M, Devarajan K, Singal AG, Marrero JA, Dai J, Feng Z, Rinaudo JA, Srivastava S, Evans A, Hann HW, Lai Y, Yang H, Block TM, Mehta A. The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma. Cancer prevention research (Philadelphia, Pa). 2016 Feb;9(2):172-9.   PMCID: PMC4740237
Zou ZW, Ma C, Medoro L, Chen L, Wang B, Gupta R, Liu T, Yang XZ, Chen TT, Wang RZ, Zhang WJ, Li PD. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells. Oncotarget. 2016 Sep 20;7(38):61741-54.   PMCID: PMC5308687
Adams DL, Stefansson S, Haudenschild C, Martin SS, Charpentier M, Chumsri S, Cristofanilli M, Tang CM, Alpaugh RK. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch((R)) CTC test. Cytometry A. 2015 Feb;87(2):137-44.
Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J, Aldulaimi D, Ho KY, Odze R, Meltzer SJ, Quigley E, Gittens S, Watson P, Zaninotto G, Iyer PG, Alexandre L, Ang Y, Callaghan J, Harrison R, Singh R, Bhandari P, Bisschops R, Geramizadeh B, Kaye P, Krishnadath S, Fennerty MB, Manner H, Nason KS, Pech O, Konda V, Ragunath K, Rahman I, Romero Y, Sampliner R, Siersema PD, Tack J, Tham TC, Trudgill N, Weinberg DS, Wang J, Wang K, Wong JY, Attwood S, Malfertheiner P, MacDonald D, Barr H, Ferguson MK, Jankowski J. BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015 Apr 14;110(5):662-82.   PMCID: 4436697
Bhatia A, Burtness B. Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials. J Clin Oncol. 2015 Oct 10;33(29):3243-50.   PMCID: PMC5814107
El-Deiry WS, Vijayvergia N, Xiu J, Scicchitano A, Lim B, Yee NS, Harvey HA, Gatalica Z, Reddy S. Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites. Cancer Biol Ther. 2015 Jan;16(12):1726-37.   PMCID: PMC4847814
Marks EI, Tan C, Zhang J, Zhou L, Yang Z, Scicchitano A, El-Deiry WS. Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy. Cancer Biol Ther. 2015 Jan;16(12):1710-9.   PMCID: PMC4847811
Marks EI, Brennan M, El-Deiry WS. Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma. Cancer Biology & Therapy. 2015 Aug;16(8):1136-9.   PMCID: 4622690
Smaglo BG, Tesfaye A, Halfdanarson TR, Meyer JE, Wang J, Gatalica Z, Reddy S, Arguello D, Boland PM. Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas. Oncotarget. 2015 Dec 22;6(41):43594-604.   PMCID: PMC4791253
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Tumor Biomarkers

Tumor Biomarkers Middle Aged Male Female pathology Adult genetics blood analysis Aged metabolism Neoplasm Staging diagnosis methods therapy therapeutic use drug therapy Prognosis Disease-Free Survival Case-Control Studies Follow-Up Studies administration & dosage Colorectal Neoplasms DNA Methylation Risk Factors Young Adult Squamous Cell Carcinoma Treatment Outcome Antineoplastic Combined Chemotherapy Protocols adverse effects Renal Cell Carcinoma Biopsy Age Factors chemistry Adenocarcinoma metastatic colorectal adenocarcinoma Cell Proliferation prevention & control Immunohistochemistry antagonists & inhibitors Hepatocellular Carcinoma Neoplasm Metastasis Kidney Neoplasms Liver Neoplasms virology Fluorouracil surgery complications Prostatic Neoplasms colorectal cancer immunology 80 and over Aged ROC Curve Head and Neck Neoplasms radiotherapy Polymerase Chain Reaction Prospective Studies Kaplan-Meier Estimate High-Throughput Nucleotide Sequencing Organoplatinum Compounds drug effects Immunoenzyme Techniques Neoplasm Antigens Keratins Esophageal Neoplasms Pyrazines Circulating Neoplastic Cells C-Type Lectins Cimp Up-Regulation Proto-Oncogene Proteins CTC cytometry mTOR pathway X-Ray Computed Tomography Lung Neoplasms Flow Cytometry bcl-2-Associated X Protein Anus Neoplasms Mutation Neoplastic Stem Cells Glycolysis Cyclooxygenase 2 Ki-67 Antigen intrahepatic China Intrahepatic Bile Ducts Barrett Esophagus Chemoradiotherapy epidemiology Esophagus Ca 19-9 Gene Amplification Gene Expression Profiling CA-19-9 Antigen Soft Tissue Neoplasms Disease Progression Chronic Hepatitis C Small Interfering RNA Multivariate Analysis Amino acids glucose metabolism Cisplatin Area Under Curve Phenylurea Compounds Carcinogenesis Leucovorin Breast Neoplasms Pancreatitis-Associated Proteins Proto-Oncogene Proteins p21(ras) Cox2 Dose Fractionation Early Detection of Cancer azacitidine transplantation Carcinoma Kras Transcriptome capecitabine Type II DNA Topoisomerases Clinical Trials as Topic extrahepatic Positron-Emission Tomography Capecitabine Proportional Hazards Models Hematopoietic Stem Cell Transplantation c-MET Cellular Immunity Liver Cirrhosis Proto-Oncogene Proteins c-bcl-2 Circulating Tumor Cells Sarcoma Diagnostic Imaging chemotherapy tumor profile oxaliplatin Biological Models Apc etiology Primary Prevention Vimentin Bile Duct Neoplasms cytology CD45 Antigens alpha-Fetoproteins Rectal Neoplasms CCR5 Receptor Antagonists Algorithms liquid biopsy Colonic Neoplasms Neoplastic Gene Expression Regulation
Last updated on Friday, January 03, 2020